These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 31694904)
1. A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells. Umeh-Garcia M; Simion C; Ho PY; Batra N; Berg AL; Carraway KL; Yu A; Sweeney C Cancer Res; 2020 Feb; 80(3):418-429. PubMed ID: 31694904 [TBL] [Abstract][Full Text] [Related]
2. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer. Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387 [TBL] [Abstract][Full Text] [Related]
3. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer. Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24. Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450 [TBL] [Abstract][Full Text] [Related]
5. miR-506-loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple-negative breast cancer aggressiveness. Liu XL; Liu WJ; Chen Q; Liu J; Yang CQ; Zhang G; Zhang SL; Guo WH; Li JB; Zhao G; Yin DC; Zhang CY Mol Carcinog; 2021 Aug; 60(8):538-555. PubMed ID: 34062009 [TBL] [Abstract][Full Text] [Related]
6. CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression. Kong Y; Yang L; Wei W; Lyu N; Zou Y; Gao G; Ou X; Xie X; Tang H Epigenomics; 2019 Aug; 11(10):1163-1176. PubMed ID: 31337246 [No Abstract] [Full Text] [Related]
7. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer. Ring A; Kaur P; Lang JE BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919 [TBL] [Abstract][Full Text] [Related]
8. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer. Yu TJ; Liu YY; Li XG; Lian B; Lu XX; Jin X; Shao ZM; Hu X; Di GH; Jiang YZ Cancer Res; 2021 Nov; 81(21):5491-5505. PubMed ID: 34408002 [TBL] [Abstract][Full Text] [Related]
9. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling. Zheng S; Li M; Miao K; Xu H J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053 [TBL] [Abstract][Full Text] [Related]
10. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer. Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392 [TBL] [Abstract][Full Text] [Related]
11. MiR-296-3p inhibits cell proliferation by the SOX4-Wnt/βcatenin pathway in triple-negative breast cancer. Tian D; Luo L; Wang T; Qiao J J Biosci; 2021; 46():. PubMed ID: 34785625 [TBL] [Abstract][Full Text] [Related]
12. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway. Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899 [TBL] [Abstract][Full Text] [Related]
13. E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer. Chen HA; Chang YW; Tseng CF; Chiu CF; Hong CC; Wang W; Wang MY; Hsiao M; Ma JT; Chen CH; Jiang SS; Wu CH; Hung MC; Huang MT; Su JL Ann Surg Oncol; 2015 Mar; 22(3):889-98. PubMed ID: 25212833 [TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer. Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586 [TBL] [Abstract][Full Text] [Related]
15. Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer. Gagliardi M; Pitner MK; Park J; Xie X; Saso H; Larson RA; Sammons RM; Chen H; Wei C; Masuda H; Chauhan G; Kondo K; Tripathy D; Ueno NT; Dalby KN; Debeb BG; Bartholomeusz C Sci Rep; 2020 May; 10(1):8537. PubMed ID: 32444778 [TBL] [Abstract][Full Text] [Related]
16. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Guo GC; Wang JX; Han ML; Zhang LP; Li L Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267 [TBL] [Abstract][Full Text] [Related]
18. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway. Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204 [TBL] [Abstract][Full Text] [Related]
19. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis. Humphries B; Wang Z; Oom AL; Fisher T; Tan D; Cui Y; Jiang Y; Yang C Carcinogenesis; 2014 Oct; 35(10):2254-63. PubMed ID: 24925028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]